Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Jun 9, 2011	CORRESP	CORRESP	View HTML 0001144204-11-034833.pdf 0001144204-11-034833.rtf 0001144204-11-034833.xls
May 27, 2011	CORRESP	CORRESP	View HTML 0001144204-11-032937.pdf 0001144204-11-032937.rtf
May 26, 2011	UPLOAD	UPLOAD	View HTML 0000000000-11-033021.pdf
May 17, 2011	NT 10-Q	Notification that form type 10-Q will be submitted late	View HTML 0001144204-11-030413.pdf 0001144204-11-030413.rtf 0001144204-11-030413.xls
May 17, 2011	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001144204-11-030414.pdf 0001144204-11-030414.rtf 0001144204-11-030414.xls
May 17, 2011	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-11-030616.pdf 0001144204-11-030616.rtf 0001144204-11-030616.xls
May 3, 2011	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-11-025796.pdf 0001144204-11-025796.rtf 0001144204-11-025796.xls
May 2, 2011	10-K/A	Amendment to a previously filed 10-K	View HTML 0001144204-11-025440.pdf 0001144204-11-025440.rtf 0001144204-11-025440.xls
May 2, 2011	S-3	Simplified registration form	View HTML 0001144204-11-025446.pdf 0001144204-11-025446.rtf 0001144204-11-025446.xls
May 2, 2011	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001144204-11-025452.pdf 0001144204-11-025452.rtf 0001144204-11-025452.xls